Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Main Targets of Interest for the Development of a Prophylactic or Therapeutic Epstein-Barr Virus Vaccine
Vincent Jean-Pierre, Julien Lupo, Marlyse Buisson, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Immunotherapy for nasopharyngeal carcinoma: Current status and prospects (Review)
Huageng Huang, Yuyi Yao, Xinyi Deng, et al.
International Journal of Oncology (2023) Vol. 63, Iss. 2
Open Access | Times Cited: 47
Immunotherapeutic approaches in EBV-associated nasopharyngeal carcinoma
Wenting Li, Xiaobing Duan, Xingxing Chen, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 40
Lymph node targeted multi-epitope subunit vaccine promotes effective immunity to EBV in HLA-expressing mice
Vijayendra Dasari, Lisa K. McNeil, Kirrilee Beckett, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 31
Epstein-Barr virus infection: the micro and macro worlds
Wei Huang, Lang Bai, Hong Tang
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 28
Infectious Mononucleosis: An Updated Review
Alexander K. C. Leung, Joseph M. Lam, Benjamin Barankin
Current Pediatric Reviews (2023) Vol. 20, Iss. 3, pp. 305-322
Closed Access | Times Cited: 25
Epstein-Barr virus-infected nasopharyngeal carcinoma therapeutics: oncoprotein targets and clinical implications
Jacqueline Kar Kei Mark, Aik-Hong Teh, Beow Keat Yap
Medical Oncology (2025) Vol. 42, Iss. 3
Closed Access | Times Cited: 1
Virological Markers in Epstein–Barr Virus-Associated Diseases
Julien Lupo, Aurélie Truffot, Julien Andréani, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 656-656
Open Access | Times Cited: 19
Increased Prevalence of EBV Infection in Nasopharyngeal Carcinoma Patients: A Six-Year Cross-Sectional Study
Abdullah E. Al-Anazi, Bader S. Alanazi, Huda M. Alshanbari, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 643-643
Open Access | Times Cited: 14
Epstein–Barr Viruses: Their Immune Evasion Strategies and Implications for Autoimmune Diseases
Yuehong Zhao, Qi Zhang, Botian Zhang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8160-8160
Open Access | Times Cited: 5
Progress in Prophylactic and Therapeutic EBV Vaccine Development Based on Molecular Characteristics of EBV Target Antigens
Marija Rozman, Petra Korać, Karlo Jambrosic, et al.
Pathogens (2022) Vol. 11, Iss. 8, pp. 864-864
Open Access | Times Cited: 21
Mini-review on the therapeutic vaccines targeting chronic infectious diseases: Evaluation system of therapeutic vaccines targeting HPV and EBV-related cancers
Seungkyun Woo, Pil‐Gu Park, Timothy An, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
A Comparative Genomic Analysis of Epstein–Barr Virus Strains with a Focus on EBV2 Variability
Ana Catalina Blazquez, Marı́a Dolores Fellner, Mario Alejandro Lorenzetti, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2708-2708
Open Access
Epstein–Barr Infection, Hodgkin’s Lymphoma, and the Immune System: Insights into the Molecular Mechanisms Facilitating Immune Evasion
Eleni Tsotridou, Emmanuel Hatzipantelis
Cancers (2025) Vol. 17, Iss. 9, pp. 1481-1481
Open Access
Neutralizing antibodies against EBV gp42 show potent in vivo protection and define novel epitopes
Qian Wu, L. Zhong, Dongmei Wei, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 9
Wildebeest-Derived Malignant Catarrhal Fever: A Bovine Peripheral T Cell Lymphoma Caused by Cross-Species Transmission of Alcelaphine Gammaherpesvirus 1
Meijiao Gong, Françoise Myster, Willem Van Campe, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 526-526
Open Access | Times Cited: 7
Designing a vaccine-based therapy against Epstein-Barr virus-associated tumors using immunoinformatics approach
Victor Omoboyede, Ochapa Ibrahim, Haruna Isiyaku Umar, et al.
Computers in Biology and Medicine (2022) Vol. 150, pp. 106128-106128
Closed Access | Times Cited: 9
A review: cellular attachment and entry factors of human tumor-associated viruses
Duo Shi, Yan Zhang, Bing Luo
Future Virology (2024)
Closed Access | Times Cited: 1
Molecular Characterisation of Epstein–Barr Virus in Classical Hodgkin Lymphoma
Valerija Begić, Petra Korać, Slavko Gašparov, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15635-15635
Open Access | Times Cited: 7
Precision Vaccine Development: Unraveling the Immunoinformatics Code Against Epstein-Barr Virus's T41 Glycoprotein 350/220
Saba Beigh
Natural Resources for Human Health (2024) Vol. 4, Iss. 2, pp. 194-207
Open Access
A review: cellular attachment and entry factors of human tumor-associated viruses
Duo Shi, Yan Zhang, Bing Luo
Future Virology (2024) Vol. 19, Iss. 2-4, pp. 145-160
Closed Access
Multiple Sclerosis, Viruses, and New Vaccines
P.A.C. Maple
Neurology International (2021) Vol. 13, Iss. 4, pp. 712-714
Open Access | Times Cited: 1
EBV, Mononukleose
Volker Schuster
Elsevier eBooks (2023), pp. 160-162
Closed Access
Therapeutic cancer vaccines targeting viral antigens
Cornelis J.M. Melief, Anna‐Sophia Wiekmeijer, Esmé T.I. van der Gracht
Elsevier eBooks (2022), pp. 97-107
Closed Access
Epstein-Barr-Virus-assoziierte Erkrankungen bei Kindern und Jugendlichen
Jonas Geisperger, Uta Behrends
Kinder- und Jugendmedizin (2022) Vol. 22, Iss. 03, pp. 149-157
Closed Access
A Lymph Node Targeted Adjuvant and Engineered Subunit Vaccine Promotes Potent Immunity to Epstein-Barr Virus in HLA-expressing Mice
Vijayendra Dasari, Lisa K. McNeil, Kirrilee Beckett, et al.
Research Square (Research Square) (2022)
Open Access
Page 1 - Next Page

Scroll to top